Recent publications
Article
PD Med Collaborative Group 2021, 'Cost-effectiveness of dopamine agonists and monoamine oxidase B inhibitors in early Parkinson's disease', Movement Disorders. https://doi.org/10.1002/mds.28623
Scobie , S, Jowett, S, Lambe, T, Patel, S, Woolley, R, Rowland, N, Rick, C, Smith, C, Brady , M, Clarke, CE & Sackley, C 2021, 'Lee Silverman voice treatment versus standard speech and language therapy versus control in Parkinson’s disease: preliminary cost-consequence analysis of the PD COMM pilot randomised controlled trial', Pilot and Feasibility Studies, vol. 7, no. 1, 154. https://doi.org/10.1186/s40814-021-00888-y
Sackley, C, Rick, C, Au, P, Brady , MC, Beaton , G, Burton, C, Caulfield, M, Dickson , S, Dowling, F, Hughes, M, Rowland, N, Jowett, S, Masterson-Algar, P, Nicoll , A, Patel, S, Smith , CH, Woolley, R & Clarke, CE 2020, 'A multi-centre randomised controlled trial to compare the clinical and cost effectiveness of Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson’s disease: a study protocol for a randomised controlled trial', Trials, vol. 21, no. 1, 436. https://doi.org/10.1186/s13063-020-04354-7
Lang, AE, de Bie, RMA, Clarke, CE, Espay, AJ & Fox, SH 2020, 'Initiating pharmacotherapy in early Parkinson's disease', The Lancet Neurology, vol. 19, no. 8, pp. 643-644. https://doi.org/10.1016/S1474-4422(20)30225-8
Herd, C, Tomlinson, C, Rick, C, Scotton, W, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2019, 'Cochrane systematic review and meta-analysis of Botulinum toxin for the prevention of migraine', BMJ open, vol. 9, no. 7, e027953. https://doi.org/10.1136/bmjopen-2018-027953
Smith, CH, Patel, S, Woolley, RL, Brady, MC, Rick, CE, Halfpenny, R, Rontiris, A, Knox-Smith, L, Dowling, F, Clarke, CE, Au, P, Ives, N, Wheatley, K & Sackley, CM 2019, 'Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners', Clinical Linguistics & Phonetics, vol. 33, no. 10-11, pp. 1063-1070. https://doi.org/10.1080/02699206.2019.1604806
American Genome Center 2019, 'The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight', Movement Disorders, vol. 34, no. 12, pp. 1851-1863. https://doi.org/10.1002/mds.27864
Herd, C, Cl, T, Rick, C, Scotton, WJ, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2018, 'Botulinum toxins for the prevention of migraine in adults', Cochrane Database of Systematic Reviews, no. 6, CD011616. https://doi.org/10.1002/14651858.CD011616.pub2
Sackley, CM, Smith, CH, Rick, C, Brady, MC, Ives, N, Patel, S, Woolley, R, Dowling, F, Patel, R, Roberts, H, Jowett, S, Wheatley, K, Kelly, D, Sands, G, Clarke, CE & PD COMM Pilot Collaborative Group 2018, 'Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: a pilot randomised controlled trial (PD COMM pilot)', Pilot and Feasibility Studies, vol. 4, no. 30. https://doi.org/10.1186/s40814-017-0222-z
Muzerengi, S, Rick, C, Begaj, I, Ives, N, Evison, F, Woolley, RL & Clarke, CE 2017, 'Coding accuracy for Parkinson's disease hospital admissions: implications for healthcare planning in the UK', Public Health, vol. 146, pp. 4-9. https://doi.org/10.1016/j.puhe.2016.12.024
Masterson-Algar, P, Burton, CR, Brady, MC, Nicoll, A, Clarke, CE, Rick, C, Hughes, M, Au, P, Smith, CH & Sackley, CM 2017, 'The PD COMM trial: a protocol for the process evaluation of a randomised trial assessing the effectiveness of two types of SLT for people with Parkinson's disease', Trials, vol. 18, no. 1, pp. 397. https://doi.org/10.1186/s13063-017-2130-1
Muzerengi, S, Herd, C, Rick, C & Clarke, CE 2016, 'A systematic review of interventions to reduce hospitalisation in Parkinson's disease', Parkinsonism and Related Disorders. https://doi.org/10.1016/j.parkreldis.2016.01.011
Clarke, CE, Patel, S, Ives, N, Rick, CE, Woolley, R, Wheatley, K, Walker, MF, Zhu, S, Kandiyali, R, Yao, G & Sackley, CM 2016, 'Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial (PD REHAB)', Health Technology Assessment, vol. 20, no. 63, pp. 1-124. https://doi.org/10.3310/hta20630
Review article
de Bie, RMA, Clarke, CE, Espay, AJ, Fox, SH & Lang, AE 2020, 'Initiation of pharmacological therapy in Parkinson's disease: when, why, and how', The Lancet Neurology, vol. 19, no. 5, pp. 452-461. https://doi.org/10.1016/S1474-4422(20)30036-3
Herd, CP, Tomlinson, CL, Rick, C, Scotton, WJ, Edwards, J, Ives, N, Clarke, CE & Sinclair, A 2018, 'Botulinum toxins for the prevention of migraine in adults', Cochrane Database of Systematic Reviews, vol. 6, CD011616. https://doi.org/10.1002/14651858.CD011616.pub2
View all publications in research portal